RE:Now in month four of cease trading order...This is all on Tripp and is inability to execute.
Look at the patents, the Board of Directors, the Scientific Board, the Drs of Ongology at Care Oncology, Ichor Blood and the warrant holders and finaciers. Many people saw the potential of this product but Tripp's lack of business acumen and his inability to sell killed this company.
Tripp needs to be replaced immediately and maybe the company has patents/assets worth something for a small buyout to give something back to shareholders.